The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Neisseria meningitidis Infections Drug Revenue 1.5 Market Analysis by Type 1.5.1 Global Neisseria meningitidis Infections Drug Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 MGBBP-3 1.5.3 NCL-195 1.5.4 TP-10 1.5.5 Others 1.6 Market by Application 1.6.1 Global Neisseria meningitidis Infections Drug Market Share by Application: 2021-2026 1.6.2 Hospital 1.6.3 Clinic 1.6.4 Others 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Neisseria meningitidis Infections Drug Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Neisseria meningitidis Infections Drug Market Players Profiles 3.1 Beijing Minhai Biotechnology Co Ltd 3.1.1 Beijing Minhai Biotechnology Co Ltd Company Profile 3.1.2 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product Specification 3.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 MGB Biopharma Ltd 3.2.1 MGB Biopharma Ltd Company Profile 3.2.2 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product Specification 3.2.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 GlaxoSmithKline Plc 3.3.1 GlaxoSmithKline Plc Company Profile 3.3.2 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product Specification 3.3.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 Biological E Ltd 3.4.1 Biological E Ltd Company Profile 3.4.2 Biological E Ltd Neisseria meningitidis Infections Drug Product Specification 3.4.3 Biological E Ltd Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 JN-International Medical Corp 3.5.1 JN-International Medical Corp Company Profile 3.5.2 JN-International Medical Corp Neisseria meningitidis Infections Drug Product Specification 3.5.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 China National Pharmaceutical Group Corp 3.6.1 China National Pharmaceutical Group Corp Company Profile 3.6.2 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product Specification 3.6.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Pfizer Inc 3.7.1 Pfizer Inc Company Profile 3.7.2 Pfizer Inc Neisseria meningitidis Infections Drug Product Specification 3.7.3 Pfizer Inc Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 ImmunoBiology Ltd 3.8.1 ImmunoBiology Ltd Company Profile 3.8.2 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product Specification 3.8.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 Griffith University 3.9.1 Griffith University Company Profile 3.9.2 Griffith University Neisseria meningitidis Infections Drug Product Specification 3.9.3 Griffith University Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 Panacea Biotec Ltd 3.10.1 Panacea Biotec Ltd Company Profile 3.10.2 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product Specification 3.10.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.11 Sanofi Pasteur SA 3.11.1 Sanofi Pasteur SA Company Profile 3.11.2 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product Specification 3.11.3 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.12 Serum Institute of India Ltd 3.12.1 Serum Institute of India Ltd Company Profile 3.12.2 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product Specification 3.12.3 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.13 Wellstat Vaccines LLC 3.13.1 Wellstat Vaccines LLC Company Profile 3.13.2 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product Specification 3.13.3 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Neisseria meningitidis Infections Drug Market Competition by Market Players 4.1 Global Neisseria meningitidis Infections Drug Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Neisseria meningitidis Infections Drug Revenue Market Share by Market Players (2015-2020) 4.3 Global Neisseria meningitidis Infections Drug Average Price by Market Players (2015-2020) 5 Global Neisseria meningitidis Infections Drug Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Neisseria meningitidis Infections Drug Market Size (2015-2020) 5.1.2 Neisseria meningitidis Infections Drug Key Players in North America (2015-2020) 5.1.3 North America Neisseria meningitidis Infections Drug Market Size by Type (2015-2020) 5.1.4 North America Neisseria meningitidis Infections Drug Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Neisseria meningitidis Infections Drug Market Size (2015-2020) 5.2.2 Neisseria meningitidis Infections Drug Key Players in East Asia (2015-2020) 5.2.3 East Asia Neisseria meningitidis Infections Drug Market Size by Type (2015-2020) 5.2.4 East Asia Neisseria meningitidis Infections Drug Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Neisseria meningitidis Infections Drug Market Size (2015-2020) 5.3.2 Neisseria meningitidis Infections Drug Key Players in Europe (2015-2020) 5.3.3 Europe Neisseria meningitidis Infections Drug Market Size by Type (2015-2020) 5.3.4 Europe Neisseria meningitidis Infections Drug Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Neisseria meningitidis Infections Drug Market Size (2015-2020) 5.4.2 Neisseria meningitidis Infections Drug Key Players in South Asia (2015-2020) 5.4.3 South Asia Neisseria meningitidis Infections Drug Market Size by Type (2015-2020) 5.4.4 South Asia Neisseria meningitidis Infections Drug Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Neisseria meningitidis Infections Drug Market Size (2015-2020) 5.5.2 Neisseria meningitidis Infections Drug Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Neisseria meningitidis Infections Drug Market Size by Type (2015-2020) 5.5.4 Southeast Asia Neisseria meningitidis Infections Drug Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Neisseria meningitidis Infections Drug Market Size (2015-2020) 5.6.2 Neisseria meningitidis Infections Drug Key Players in Middle East (2015-2020) 5.6.3 Middle East Neisseria meningitidis Infections Drug Market Size by Type (2015-2020) 5.6.4 Middle East Neisseria meningitidis Infections Drug Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Neisseria meningitidis Infections Drug Market Size (2015-2020) 5.7.2 Neisseria meningitidis Infections Drug Key Players in Africa (2015-2020) 5.7.3 Africa Neisseria meningitidis Infections Drug Market Size by Type (2015-2020) 5.7.4 Africa Neisseria meningitidis Infections Drug Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Neisseria meningitidis Infections Drug Market Size (2015-2020) 5.8.2 Neisseria meningitidis Infections Drug Key Players in Oceania (2015-2020) 5.8.3 Oceania Neisseria meningitidis Infections Drug Market Size by Type (2015-2020) 5.8.4 Oceania Neisseria meningitidis Infections Drug Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Neisseria meningitidis Infections Drug Market Size (2015-2020) 5.9.2 Neisseria meningitidis Infections Drug Key Players in South America (2015-2020) 5.9.3 South America Neisseria meningitidis Infections Drug Market Size by Type (2015-2020) 5.9.4 South America Neisseria meningitidis Infections Drug Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Neisseria meningitidis Infections Drug Market Size (2015-2020) 5.10.2 Neisseria meningitidis Infections Drug Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Neisseria meningitidis Infections Drug Market Size by Type (2015-2020) 5.10.4 Rest of the World Neisseria meningitidis Infections Drug Market Size by Application (2015-2020) 6 Global Neisseria meningitidis Infections Drug Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Neisseria meningitidis Infections Drug Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Neisseria meningitidis Infections Drug Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Neisseria meningitidis Infections Drug Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Neisseria meningitidis Infections Drug Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Neisseria meningitidis Infections Drug Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Neisseria meningitidis Infections Drug Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Neisseria meningitidis Infections Drug Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Neisseria meningitidis Infections Drug Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Neisseria meningitidis Infections Drug Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Neisseria meningitidis Infections Drug Consumption by Countries 7 Global Neisseria meningitidis Infections Drug Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Neisseria meningitidis Infections Drug (2021-2026) 7.2 Global Forecasted Revenue of Neisseria meningitidis Infections Drug (2021-2026) 7.3 Global Forecasted Price of Neisseria meningitidis Infections Drug (2021-2026) 7.4 Global Forecasted Production of Neisseria meningitidis Infections Drug by Region (2021-2026) 7.4.1 North America Neisseria meningitidis Infections Drug Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Neisseria meningitidis Infections Drug Production, Revenue Forecast (2021-2026) 7.4.3 Europe Neisseria meningitidis Infections Drug Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Neisseria meningitidis Infections Drug Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Neisseria meningitidis Infections Drug Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Neisseria meningitidis Infections Drug Production, Revenue Forecast (2021-2026) 7.4.7 Africa Neisseria meningitidis Infections Drug Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Neisseria meningitidis Infections Drug Production, Revenue Forecast (2021-2026) 7.4.9 South America Neisseria meningitidis Infections Drug Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Neisseria meningitidis Infections Drug Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Neisseria meningitidis Infections Drug by Application (2021-2026) 8 Global Neisseria meningitidis Infections Drug Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Neisseria meningitidis Infections Drug by Country 8.2 East Asia Market Forecasted Consumption of Neisseria meningitidis Infections Drug by Country 8.3 Europe Market Forecasted Consumption of Neisseria meningitidis Infections Drug by Countriy 8.4 South Asia Forecasted Consumption of Neisseria meningitidis Infections Drug by Country 8.5 Southeast Asia Forecasted Consumption of Neisseria meningitidis Infections Drug by Country 8.6 Middle East Forecasted Consumption of Neisseria meningitidis Infections Drug by Country 8.7 Africa Forecasted Consumption of Neisseria meningitidis Infections Drug by Country 8.8 Oceania Forecasted Consumption of Neisseria meningitidis Infections Drug by Country 8.9 South America Forecasted Consumption of Neisseria meningitidis Infections Drug by Country 8.10 Rest of the world Forecasted Consumption of Neisseria meningitidis Infections Drug by Country 9 Global Neisseria meningitidis Infections Drug Sales by Type (2015-2026) 9.1 Global Neisseria meningitidis Infections Drug Historic Market Size by Type (2015-2020) 9.2 Global Neisseria meningitidis Infections Drug Forecasted Market Size by Type (2021-2026) 10 Global Neisseria meningitidis Infections Drug Consumption by Application (2015-2026) 10.1 Global Neisseria meningitidis Infections Drug Historic Market Size by Application (2015-2020) 10.2 Global Neisseria meningitidis Infections Drug Forecasted Market Size by Application (2021-2026) 11 Global Neisseria meningitidis Infections Drug Manufacturing Cost Analysis 11.1 Neisseria meningitidis Infections Drug Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Neisseria meningitidis Infections Drug 12 Global Neisseria meningitidis Infections Drug Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Neisseria meningitidis Infections Drug Distributors List 12.3 Neisseria meningitidis Infections Drug Customers 12.4 Neisseria meningitidis Infections Drug Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 3,500 | Date : Mar 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 139 |
Price : US$ 3,500 | Date : Mar 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 200 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 254 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 250 |
Price : US$ 3,500 | Date : Mar 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 143 |
We will be happy to help you find what you need. Please call us or write to us: